Title:
CRYSTAL FORM OF SPHINGOSINE-1-PHOSPHATE RECEPTOR AGONIST
Document Type and Number:
WIPO Patent Application WO/2022/220598
Kind Code:
A1
Abstract:
The present invention relates to a crystal form of a sphingosine-1-phosphate receptor agonist and, more specifically, to 1-[1-chloro-6-(3-chloro-1-isopropyl-1H-indazole-5-ylmethoxy)-3,4-dihydro-naphthalene-2-ylmethyl]-piperidine-4-carboxylic acid of chemical formula 1, or a crystal form of a solvate or a pharmaceutically acceptable salt thereof.
Inventors:
KIM JI YOON (KR)
CHUN SEUL AH (KR)
PARK KI SOOK (KR)
KIM SUNG WON (KR)
CHUN SEUL AH (KR)
PARK KI SOOK (KR)
KIM SUNG WON (KR)
Application Number:
PCT/KR2022/005375
Publication Date:
October 20, 2022
Filing Date:
April 13, 2022
Export Citation:
Assignee:
LG CHEMICAL LTD (KR)
International Classes:
C07D401/12; A61K31/454; A61P25/00; A61P37/00
Domestic Patent References:
| WO2008064320A2 | 2008-05-29 |
Foreign References:
| KR20140104376A | 2014-08-28 | |||
| EP1826197A1 | 2007-08-29 | |||
| US10166250B2 | 2019-01-01 | |||
| US20080200535A1 | 2008-08-21 |
Attorney, Agent or Firm:
HANSUNG INTELLECTUAL PROPERTY (KR)
Download PDF:
Previous Patent: CRYSTALLINE FORM OF SPHINGOSINE-1-PHOSPHATE RECEPTOR AGONIST
Next Patent: CRYSTAL FORM OF SPHINGOSINE-1-PHOSPHATE RECEPTOR AGONIST
Next Patent: CRYSTAL FORM OF SPHINGOSINE-1-PHOSPHATE RECEPTOR AGONIST